• 구독신청
  • My스크랩
  • 지면신문
FNTIMES 대한민국 최고 금융 경제지
ad

Will KT&G, which is faithful to its main job, get a green light on its report card in the first year of President Bang Kyung-man's inauguration?

손원태 기자

tellme@fntimes.com

기사입력 : 2024-09-03 11:59

KT&G Breaks Q1 Reverse Growth, Posts 'Good Performance' in Q2
Bang Kyung-man reorganizes business with overseas focus after taking office
Overseas share of tobacco business at 36%, up 6% year-on-year
“50% overseas sales by 2027, 10 trillion won in annual sales”

KT&G's local factory in Indonesia. / Photo=KT&G

KT&G's local factory in Indonesia. / Photo=KT&G

[Korea Financial Times, Son Wontae] KT&G (CEO and President Bang Kyung-man) received a relatively encouraging report card for its second quarter results. In the first quarter, the company showed a reverse growth trend, with sales and operating profit falling due to sluggish domestic and overseas exports and a weak health functional food business, but unlike the previous quarter, the company's tobacco business was strong overseas, leading to favorable results. This raises the question of whether KT&G will be able to reach the KRW 6 trillion mark in annual sales this year.

KT&G's second-quarter sales amounted to KRW 1.4238 trillion, up 6.6% from the previous year (KRW 1.336 trillion). Operating profit amounted to KRW 321.5 billion, a whopping 30.6% increase from the previous year (KRW 246.1 billion). In particular, net profit for the current period amounted to KRW 318 billion, up 57.5% from the previous year (KRW 2019 billion). This is encouraging compared to Q1, when sales and operating profit income declined 7.4% and 25.2%, respectively.

KT&G's strong performance was driven by its tobacco business. Sales of domestic and overseas cigarettes, as well as e-cigarettes (Next Generation Products - a general term for next-generation cigarettes other than traditional cigarettes), the new growth engine of the future, have increased significantly. In particular, KT&G's competitiveness is also increasing due to its alliance with global tobacco giant Philip Morris International (PMI).

Looking at the detailed performance, the tobacco business posted sales of KRW 989.9 billion in the 2nd quarter, up 11.5% from the previous year (KRW 888.1 billion), and operating profit of KRW 316.4 billion, up 11% from the previous year (KRW 242.6 billion), showing double-digit growth. In particular, tobacco, a regular cigarette, performed well. Tobacco sales rose 35% from KRW 692.1 billion to KRW 788 billion, and e-cigarette (NGP) sales also edged up from KRW 190 billion to KRW 197.7 billion.

Cigarette sales volume and market share in Korea also jumped significantly. KT&G sold 10.33 billion cigarettes in the 2nd quarter, accounting for about 67% of total sales (15.42 billion cigarettes), up from 65.2% in the previous year.

International performance was also strong. Currently, KT&G has six international subsidiaries in the United States, Kazakhstan, Turkey, Taiwan, Indonesia, and Russia. It also set up production plants in four locations, including Turkey, Kazakhstan, and Indonesia, including the groundbreaking of a factory in Kazakhstan last year to use Eurasia as a foothold. The Kazakh production plant is a 200,000㎡ site that is the size of 28 soccer fields, and plans to more than halve the share of overseas sales by 2027, and through this, it also dreams of achieving KRW 10 trillion in sales.

Starting with this year's second quarter results, that dream is slowly taking shape. Sales generated from overseas subsidiaries reached KRW 172.2 billion, a 52.9% increase from the previous year (KRW 112.6 billion), and the amount of goods produced in Korea and exported was KRW 186.9 billion, a 22.2% increase from the previous year (KRW 152.9 billion). As a result, total overseas sales reached KRW 359.1 billion, up 35.3% from the previous year's KRW 265.5 billion. Overseas sales accounted for 36.3% of KT&G's total tobacco business. This is about 6%p more than the previous year's overseas share of 29.9%. Overseas cigarette sales amounted to 15.31 billion units, up 16.2% from the previous year (13.17 billion units). Sales in new market regions, particularly Africa and Latin America, accounted for 21.9%, a sharp increase from the previous quarter (15.8%). KT&G currently exports to 33 countries for NGP and 130 countries for cigarettes.

The health functional food business, represented by KGC Ginseng Corporation, also showed strong growth overseas. First of all, overall sales in the 2nd quarter were KRW 265.1 billion, which was flat compared to the previous year (KRW 260.5 billion). While the domestic health functional food market continued to decline, overseas sales grew by 38.4% to KRW 92.6 billion. As a result, overseas sales accounted for 34.9% of health functional food sales, up 10%p from the previous year (25.7%). The increase was driven by strong sales in China, mainly for 'JUNG KWAN JANG'. In the 2nd quarter, sales in China amounted to KRW 61.9 billion, accounting for 66.8% of total international sales.

KT&G President Bang Kyung-man. / Photo=KT&G

KT&G President Bang Kyung-man. / Photo=KT&G


KT&G, founded under Bang Kyung-man, dreams of 'KRW 10 trillion in annual sales'

KT&G previously welcomed Bang Kyung-man as the new head of the group in March. It has been nine years since KT&G's previous leader, Baek Bok-in, was replaced. The largest shareholder, IBK Bank, holds a 7.30% stake in KT&G, followed by the National Pension Service with 6.42% and minority shareholders with 57.43%. KT&G was previously privatized in 2002 and operated as a dispersed ownership company without an owner majority shareholder like KT and POSCO.

However, KT&G suffered measles during the appointment process of Bang, as activist funds (FCP) and the largest shareholder, IBK Bank, voted against the appointment, citing board fairness and transparency. An example is the appointment of Sohn Dong-hwan, an outside director recommended by IBK Bank, as an outside director of KT&G. It has been 18 years since 2006 that KT&G has had an outside nominee as an outside director.

President Bang has been charged with the responsibility of ensuring external growth and transparent management while maintaining internal oversight. Upon his appointment, Mr. Bang's strategy was to focus on the group's core businesses, which are overseas cigarettes, NGPs, and nutraceuticals, rather than new businesses. For the overseas business, he established Company-In-Company (CIC) and production headquarters by region to improve organizational efficiency and execution. We visited key overseas strategic countries such as Indonesia and Taiwan to communicate with employees. Internally, he also organized the 'Can Meeting' to communicate with employees in a casual manner, helping to create a flexible organizational culture.

President Bang also decided to raise the business agreement between the two companies to the next level in order to obtain permission from the U.S. FDA for PMI and KT&G NGP products. The two companies will work together to submit KT&G's NGP products to the U.S. Pre-market Tobacco Product Application (PMTA). Recently, the next generation version of KT&G's NGP product, Reel Able, called Reel Able 2.0, is also being rolled out across the country. The company has also accelerated its ESG management by increasing the number of solar facilities at its production plants. As a result, KT&G received the highest ESG rating of 'AA' from Morgan Stanley Capital International (MSCI), a global investment information provider.

KT&G was the top performer last year, with sales of KRW 5.8565 trillion. At this rate, KT&G's sales could reach KRW 6 trillion this year. With this trend, KT&G's sales are expected to exceed KRW 6 trillion this year. Attention is focusing on whether Bang will reach KRW 10 trillion in KT&G sales, following his predecessor Baek Bok-in.

"The company is pushing for global expansion and structural transformation centered on the three core businesses (NGP, overseas cigarettes, and health functional foods)," said KT&G President Bang Kyung-man. "We will do our best to achieve our future vision of 'Global Top Tier Leap' by using NGP innovative products and scientific R&D capabilities to be introduced in overseas markets."

Son Wontae (tellme@fntimes.com)

데일리 금융경제뉴스 FNTIMES - 저작권법에 의거 상업적 목적의 무단 전재, 복사, 배포 금지
Copyright ⓒ 한국금융신문 & FNTIMES.com

기자의 기사 더보기 전체보기

가장 핫한 경제 소식! 한국금융신문의 ‘추천뉴스’를 받아보세요~

유통·부동산 다른 기사

1 GTX-A 삼성역 개통 또 늦어진다…정부 안전점검 11월까지 확대 국토교통부와 행정안전부가 GTX-A 삼성역 시공오류 구간에 대한 정부 합동 안전점검을 11월까지 연장하기로 하면서 삼성역의 연내 개통이 사실상 어려워졌다. 안전성 검증 이후 보강공사와 열차 시험운행을 포함한 종합시운전 등 후속 절차가 남아 있어 GTX-A 전 구간 완전 개통도 당초 계획보다 늦어질 전망이다.국토교통부와 행정안전부는 "GTX 삼성역 시공오류 구간의 안전성을 보다 면밀히 확인하고 원인을 분석하기 위해 정부합동점검단 운영 기간을 오는 11월 20일까지 4개월 연장한다"고 20일 밝혔다.정부합동점검단은 지난 5월부터 현장 조사와 관계자 면담, 설계사·시공사·감리사가 제출한 자료 검토 등을 통해 안전관리 실태와 시공오 2 한국유니온제약, 이사회 전면 재편 부광약품이 인수한 한국유니온제약이 이사회를 전면 재편했다. 한국유니온제약은 21일 오전 경기 성남시 본사에서 임시주주총회를 열고 신임 대표이사 선임을 진행했다. 이 과정에서 기존 이사회 구성원들이 모두 물러나면서 부광약품 인사로 이사진 교체가 이뤄졌다. 새로 선임된 임원은 성광현·김성수 사내이사와 임정수·민병환 사외이사 등 4인이다.성 신임 대표이사는 한국외국어대 법학과를 나와 OCI홀딩스 인사담당 최고인사책임자(CHRO) 전무를 지냈다. 부광약품에서는 유니온제약 인수기획단(TF) 부사장으로 통합 작업을 이끌어 왔다. 김성수 신임 부사장은 삼일회계법인 등 국내 주요 회계법인을 거친 재무통이다. 2024년부터 부광약품 3 강남구 '이니그마빌2' 84평, 15.4억 오른 55억원에 거래 [일일 신고가] 서울 강남권과 여의도, 수도권 핵심 지역을 중심으로 신고가 거래가 이어졌다. 지방에서도 신축과 선호 입지를 중심으로 최고가 거래가 확산하며 전국적인 가격 강세가 지속되는 모습이다.청담·여의도 등 서울 핵심지 신고가서울에서는 강남권과 한강변 주요 단지의 신고가 거래가 두드러졌다.21일 국토교통부 실거래가공개시스템·아파트투미 등에 따르면, 이날 서울 내 가장 큰 신고가 거래가 이뤄진 단지는 강남구 청담동 소재 '이니그마빌2' 타입 230.69㎡(84평)으로 확인됐다. 이 타입은 지난 10일 55억원에 거래되며 직전 거래보다 15억4000만원 오른 평형 신고가를 기록했다.마포구 상수동 '래미안밤섬리베뉴Ⅱ' 타입 84.98㎡(32평)는 지
ad
ad

한국금융 포럼 사이버관

더보기

FT카드뉴스

더보기
환전·로또·육아휴직까지 하반기부터 달라지는 제도 TOP11
[그래픽 뉴스] 은퇴후 30년 부모님 세대의 생존전략
[그래픽 뉴스] 퇴근 후 주차했는데 수익 발생? V2G의 정체
[그래픽 뉴스] “전쟁 신호를 읽는 가장 이상한 방법, 피자 주문량”
[그래픽 뉴스] 트럼프의 ‘타코 한 입’에 흔들린 시장의 비밀

FT도서

더보기